Medscape
TOPLINE: At 1 year, 82% of patients with breast cancer who received a 1-week ultrahypofractionated breast radiotherapy regimen reported no or mild toxicities. Most patients also reported that the reduced treatment time was a major benefit of the 1-week radiotherapy schedule. METHODOLOGY: In March 2020, during the COVID-19 pandemic…
Read More
Is 1-Week Radiotherapy Safe for Breast Cancer?
Samatha Damron
22:25
TOPLINE: At 1 year, 82% of patients with breast cancer who received a 1-week ultrahypofractionated breast radiotherapy regimen reported no or mild toxicities. Most patients also reported that the reduced treatment time was a major benefit of the 1-week radiotherapy schedule. METHODOLOGY: In March 2020, during the COVID-19 pandemic…
